The largest database of trusted experimental protocols

2 protocols using u ch1

1

Culturing Human Chordoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human chordoma U-CH1, MUG-Chor1 and JHC7 cell lines were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). U-CH1 and MUG-Chor1 cells were cultured in RPMI-1640 medium (Catalog No. 11875093, Gibco, US) supplemented with an additional 1% l-glutamine (Catalog No. 25030081, Gibco, US), 10% characterized fetal bovine serum (FBS) (Catalog No. 10099141, Gibco, US), 10 units/mL penicillin and 10 mg/mL streptomycin (Catalog No. 10378016, Gibco, US). JHC7 cells were cultured in DMEM: F12 medium (ATCC® 30-2006™, ATCC, USA) supplemented with 10% FBS, 10 units/mL penicillin and 10 mg/mL streptomycin. To culture U-CH1 and MUG-Chor1 cells, coating buffer (50 μg/mL rat tail type I collagen (Catalog No. 354236, BD Biosciences) was added to the culture flask for 1 h at room temperature prior to adding the cells. The SGC-7901 (a gastric cancer cell line)-shN and sh393 cells and GES-1 (an immortalized gastric epithelial cell line)-shN and sh393 cells were obtained as previously described [32 (link)]. All cells were maintained in humidified incubators at 37 °C with 5% CO2.
+ Open protocol
+ Expand
2

Chordoma Cell Culture and Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human chordoma cell lines JHC7 and U-CH1 were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). JHC7 cells were cultured in DMEM: F12 medium (ATCC® 30-2006™, ATCC, USA) and U-CH1 cells were cultured in RPMI-1640 medium (11875093, Gibco, US) supplemented with an additional 1% L-glutamine (25030081, Gibco, US). To culture U-CH1, coating buffer (50 μg/mL rat tail type I collagen (354236, BD Biosciences) was added to the culture flask for one hour at room temperature prior to adding cells. All cells were cultured with 10% characterized fetal bovine serum (FBS) (10099141, Gibco, US), 10 units/mL penicillin and 10 mg/mL streptomycin (10378016, Gibco, US), and maintained in humidified incubators at 37°C with 5% CO2.
To knock down endogenous AURA, CDK9, and MOK, siRNA constructs were generated with the target sequences shown in Table S4. The siRNAs were purchased commercially (HanBio Inc., Shanghai, China). Chordoma cells were transfected with siRNA at a final concentration of 50 nM using Lipofectamine 3000 transfection reagent (Catalog No. L3000015, Invitrogen, USA). The suppression efficiency of AURA, CDK9, and MOK was analyzed by western blot on the third day post transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!